Pandit-Taskar, Neeta

Publications

Sort by

Co-Author Network

selected publications

Comparison of ⁶⁸Ga-DOTA-JR11 PET/CT with dosimetric ¹⁷⁷Lu-satoreotide tetraxetan (¹⁷⁷Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy. European journal of nuclear medicine and molecular imaging. 2020 Academic Article GET IT
Times cited: 14
Positron Lymphography via Intracervical ¹⁸F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2020 Academic Article GET IT
Times cited: 6
First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Academic Article GET IT
Times cited: 131
Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma. Nuclear medicine communications. 2019 Academic Article GET IT
Times cited: 12
Pharmacokinetics and Biodistribution of a [⁸⁹Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients. Molecular pharmaceutics. 2019 Academic Article GET IT
Times cited: 21
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial. European journal of cancer (Oxford, England : 1990). 2019 Academic Article GET IT
Times cited: 33
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using ⁸⁹Zr-DFO-MSTP2109A Anti-STEAP1 Antibody. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Academic Article GET IT
Times cited: 32
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer. Cancer discovery. 2018 Academic Article GET IT
Times cited: 98
Biodistribution and radiation dose estimates for ⁶⁸Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors. European journal of nuclear medicine and molecular imaging. 2018 Academic Article GET IT
Times cited: 35
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. The Lancet. Oncology. 2018 Academic Article GET IT
Times cited: 161
Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods. Seminars in hematology. 2018 Review GET IT
Times cited: 24
A phase II study of radioimmunotherapy with intraventricular ¹³¹ I-3F8 for medulloblastoma. Pediatric blood & cancer. 2017 Academic Article GET IT
Times cited: 40
Biodistribution and Dosimetry of ¹⁸F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2017 Academic Article GET IT
Times cited: 81
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for ⁸⁹Zr-Trastuzumab in Patients with Esophagogastric Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2017 Academic Article GET IT
Times cited: 82
A comparison of pediatric and adult CT organ dose estimation methods. BMC medical imaging. 2017 Academic Article GET IT
Times cited: 39
Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma. 2017 GET IT
Times cited: 8
Multifocal Osteosarcoma: Unusual Presentation and Imaging Findings. 2017 GET IT
Times cited: 7
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC). Cancer chemotherapy and pharmacology. 2017 Academic Article GET IT
Times cited: 20
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma. 2016 GET IT
Times cited: 1
Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Academic Article GET IT
Times cited: 16
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Academic Article GET IT
Times cited: 92
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. AJR. American journal of roentgenology. 2016 Academic Article GET IT
Times cited: 24
Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates. BMC medical imaging. 2016 Academic Article GET IT
Times cited: 92
I-131 Metaiodobenzylguanidine Therapy of Pheochromocytoma and Paraganglioma. Seminars in nuclear medicine. 2016 Review GET IT
Times cited: 42
Molecular Imaging of Biomarkers in Breast Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Review GET IT
Times cited: 54
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms. Pediatric blood & cancer. 2016 Academic Article GET IT
Times cited: 14
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Academic Article GET IT
Times cited: 15
Foot and Ankle Hepatocellular Carcinoma Metastasis. 2016 GET IT
Times cited: 1
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer. European journal of nuclear medicine and molecular imaging. 2015 Academic Article GET IT
Times cited: 11
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. European journal of cancer (Oxford, England : 1990). 2015 Academic Article GET IT
Times cited: 21
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 148
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes. Clinical colorectal cancer. 2015 Academic Article GET IT
Times cited: 39
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy. Journal of neuro-oncology. 2015 Academic Article GET IT
Times cited: 20
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors. EJNMMI research. 2015 Academic Article GET IT
Times cited: 111
PET Imaging of Breast Cancer: Role in Patient Management. PET clinics. 2015 Review GET IT
Times cited: 16
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. European journal of nuclear medicine and molecular imaging. 2014 Academic Article GET IT
Times cited: 112
Impact of pre-operative positron emission tomography in gallbladder cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2014 Academic Article GET IT
Times cited: 30
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. International journal of cancer. 2014 Academic Article GET IT
Times cited: 73
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer. Health physics. 2014 Academic Article GET IT
Times cited: 50
Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2013 Review GET IT
Times cited: 83
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 39
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2013 Academic Article GET IT
Times cited: 57
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer. 2013 Academic Article GET IT
Times cited: 21
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer. European journal of nuclear medicine and molecular imaging. 2013 Academic Article GET IT
Times cited: 144
Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma research. 2013 Academic Article GET IT
Times cited: 9
ACR Appropriateness Criteria ® spinal bone metastases. Journal of palliative medicine. 2012 Academic Article GET IT
Times cited: 49
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma. Investigational new drugs. 2012 Academic Article GET IT
Times cited: 112
Radionuclide therapy of adrenal tumors. Journal of surgical oncology. 2012 Review GET IT
Times cited: 29
ACR Appropriateness Criteria® non-spine bone metastases. Journal of palliative medicine. 2012 Academic Article GET IT
Times cited: 28
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011 Academic Article GET IT
Times cited: 39
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease. Leukemia & lymphoma. 2011 Academic Article GET IT
Times cited: 15
(124)I-huA33 antibody PET of colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011 Academic Article GET IT
Times cited: 73
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 70
Primary seminal vesicle adenocarcinoma. 2011 GET IT
Times cited: 14
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 205
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 147
Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology. 2010 Academic Article GET IT
Times cited: 58
Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 72
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. Journal of neuro-oncology. 2009 Academic Article GET IT
Times cited: 182
Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT. 2009 GET IT
Times cited: 4
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 80
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 184
Novel tracers and their development for the imaging of metastatic prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008 Review GET IT
Times cited: 106
F-18 FDG uptake in cutaneous metastases from breast cancer. 2008 GET IT
Times cited: 8
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008 Academic Article GET IT
Times cited: 67
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy. Pediatric blood & cancer. 2008 Academic Article GET IT
Times cited: 37
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003. Nuclear medicine and biology. 2008 Academic Article GET IT
Times cited: 45
Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma. Cancer. 2007 Academic Article GET IT
Times cited: 39
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2007 Academic Article GET IT
Times cited: 29
The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by (111)Indium-labeled humanized monoclonal antibody 3S193. European journal of radiology. 2007 Academic Article GET IT
Times cited: 5
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 71
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. The Lancet. Oncology. 2007 Academic Article GET IT
Times cited: 317
Imaging of uterine cancer. Radiologic clinics of North America. 2007 Review GET IT
Times cited: 54
Ovarian cancer. Radiologic clinics of North America. 2007 Review GET IT
Times cited: 52
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2006 Academic Article GET IT
Times cited: 62
Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2006 Academic Article GET IT
Times cited: 106
Oncologic imaging in gynecologic malignancies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Review GET IT
Times cited: 54
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 110
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer. Current urology reports. 2005 Review GET IT
Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR. American journal of roentgenology. 2004 Academic Article GET IT
Times cited: 49
Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Review GET IT
Times cited: 206
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer. Current oncology reports. 2004 Review GET IT
Molecular imaging in nuclear cardiology. Seminars in nuclear medicine. 2004 Review GET IT
Times cited: 27
New strategies in radioimmunotherapy for lymphoma. Current oncology reports. 2003 Academic Article GET IT
Times cited: 11

more ...

less ...

Background

education and training

M.D., University of the State of New York 2005
M.B.,B.S., Lady Hardinge Medical College, Delhi University (India) 1990

Contact

full name

Neeta Pandit-Taskar

VIVO Weill Cornell Medical College

Neeta Pandit-Taskar Professor of Radiology

Publications

selected publications

Background

education and training

Contact

full name